Spark Investment Management LLC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 133 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Spark Investment Management LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2015$785,000
+223.0%
99,400
+404.6%
0.10%
+194.1%
Q2 2015$243,000
-91.3%
19,700
-91.6%
0.03%
-91.2%
Q1 2015$2,781,000
+33.3%
234,100
+26.8%
0.39%
+10.5%
Q4 2014$2,087,000
+163.2%
184,600
+104.0%
0.35%
+195.0%
Q3 2014$793,00090,5000.12%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2014
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 514,853$2,595,0002.23%
GARRISON BRADFORD & ASSOCIATES INC 98,001$494,0000.48%
Catalyst Capital Advisors LLC 380,896$1,920,0000.44%
Knoll Capital Management, LLC 160,585$809,0000.42%
Tekla Capital Management LLC 757,050$3,816,0000.38%
FULLER & THALER ASSET MANAGEMENT, INC. 524,800$2,645,0000.13%
Integre Asset Management, LLC 103,493$522,0000.12%
CAMBRIDGE TRUST CO 220,003$1,109,0000.10%
JAMISON EATON & WOOD INC /NJ 62,782$316,0000.09%
STONERIDGE INVESTMENT PARTNERS LLC 88,304$445,0000.09%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders